ArticleScientific reports2020

Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer's disease risk.

Josue D Gonzalez Murcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.